Ipsen S.A. IPSEY
43.67 USD -0.05 (-0.12%)
At closeNov 4, 2026, 4:00 PM EST
42.70 Day range 42.76
34.34 52-week range 51.10
- YTD
- +20.09%
- 1 year
- +21.03%
News
seekingalpha.com Ipsen S.A. (IPSEY) Q2 2026 Sales/Trading Call Transcript Ipsen S.A. (IPSEY) Q2 2026 Sales/Trading Call Transcript
defenseworld.net IPSEN (OTCMKTS:IPSEY) Shares Gap Down – Should You Sell? IPSEN (OTCMKTS:IPSEY - Get Free Report)'s stock price gapped down before the market opened on Monday. The stock had previously closed at $41.8975, but opened at $39.40. IPSEN shares last traded at…
defenseworld.net IPSEN (OTCMKTS:IPSEY) Given Consensus Rating of “Hold” by Analysts Shares of IPSEN (OTCMKTS:IPSEY - Get Free Report) have received an average recommendation of "Hold" from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. Two analysts…
seekingalpha.com Ipsen S.A. (IPSEY) Q2 2026 Earnings Call Transcript Ipsen S.A. (IPSEY) Q2 2026 Earnings Call Transcript
seekingalpha.com Ipsen S.A. (IPSEY) Discusses Phase II LANTIC Data and Innovation in Engineered Neuroinhibitors for Aesthetic Indications Transcript Ipsen S.A. (IPSEY) Discusses Phase II LANTIC Data and Innovation in Engineered Neuroinhibitors for Aesthetic Indications Transcript
globenewswire.com Annual General Meeting of Ipsen S.A. held on 13 May 2026 Annual General Meeting of Ipsen S.A. held on 13 May 2026 All the resolutions submitted to the shareholders' vote have been adopted PARIS, FRANCE, 13 MAY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY)…
globenewswire.com Ipsen S.A. – Evolution of the composition of the Board of Directors Ipsen S.A. – Evolution of the composition of the Board of Directors PARIS, FRANCE, 13 MAY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that Mrs. Karen Witts has resigned from her position…
seekingalpha.com Ipsen S.A. (IPSEY) Q1 2026 Earnings Call Transcript Ipsen S.A. (IPSEY) Q1 2026 Earnings Call Transcript
defenseworld.net IPSEN (OTCMKTS:IPSEY) Shares Cross Above Two Hundred Day Moving Average – Should You Sell? IPSEN (OTCMKTS:IPSEY - Get Free Report) crossed above its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $38.24 and traded as high as…
globenewswire.com Ipsen S.A. publishes its 2025 Consolidated Financial Statements Ipsen S.A. publishes its 2025 Consolidated Financial Statements Attachment Ipsen_Consolidated financial statements 2025_GB
globenewswire.com GENFIT to receive US$20M milestone after Ipsen's Iqirvo® exceeds the US$200M threshold in its first full year of net sales Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), February 12, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients…
seekingalpha.com Ipsen S.A. (IPSEY) Q4 2025 Earnings Call Transcript Ipsen S.A. (IPSEY) Q4 2025 Earnings Call Transcript
defenseworld.net IPSEN (OTCMKTS:IPSEY) Shares Gap Up – What’s Next? IPSEN (OTCMKTS:IPSEY - Get Free Report) gapped up prior to trading on Wednesday. The stock had previously closed at $34.93, but opened at $36.3596. IPSEN shares last traded at $36.3596, with a volume…
defenseworld.net IPSEN (OTCMKTS:IPSEY) Shares Pass Above Two Hundred Day Moving Average – Time to Sell? Shares of IPSEN (OTCMKTS:IPSEY - Get Free Report) crossed above its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $33.27 and traded as…
defenseworld.net IPSEN (OTCMKTS:IPSEY) Shares Pass Above 200 Day Moving Average – What’s Next? IPSEN (OTCMKTS:IPSEY - Get Free Report) crossed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $33.02 and traded as high as $35.55. IPSEN…
seekingalpha.com Ipsen S.A. (IPSEY) Q3 2025 Earnings Call Transcript Ipsen S.A. (OTCPK:IPSEY) Q3 2025 Earnings Call October 22, 2025 7:00 AM EDT Company Participants David Loew - MD, CEO & Director Aymeric Le Chatelier - Executive VP & CFO Christelle Huguet -…
globenewswire.com Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025) Ipsen S.A. publishes its 2025 Half-Year Report (half-year ended 30 June 2025) Attachment 2025 Half-year Financial Report_Ipsen SA
globenewswire.com Ipsen S.A. - Initiation of the share buy-back program Regulated information Ipsen initiates a share buy-back program to cover its free employee share-allocation plan PARIS, FRANCE, 2 June 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that it…
globenewswire.com Ipsen S.A. - Annual General Meeting held on 21 May 2025 Annual General Meeting of Ipsen S.A. held on 21 May 2025 All the resolutions submitted to the shareholders' vote have been adopted PARIS, FRANCE, 21 May 2025 - Ipsen (Euronext: IPN; ADR: IPSEY)…
globenewswire.com GENFIT to receive a €26.5 million milestone payment following the approval of pricing and reimbursement of Ipsen's Iqirvo® in Italy Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 20, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of…
benzinga.com Eton Pharmaceuticals Enters Asset Purchase Agreement To Acquire Increlex (Mecasermin Injection) From Ipsen; No Terms Disclosed Increlex is a biologic product used to treat children and adolescents from 2- to 18-years-old who suffer from severe primary insulin-like growth factor 1 deficiency (SPIGFD) because their bodies do…- benzinga.com Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know Editor's note: This story has been corrected to reflect that the FDA deferred action on Amicus Therapeutics' Biologics License Application.
benzinga.com This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
benzinga.com Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.- benzinga.com Stocks That Hit 52-Week Highs On Tuesday
benzinga.com Stocks That Hit 52-Week Lows On Friday 
benzinga.com Stocks That Hit 52-Week Lows On Thursday - benzinga.com Stocks That Hit 52-Week Lows On Friday
- benzinga.com Stocks That Broke Yearly Lows Tuesday Morning